The Spoken Word Project: Using Poetry in Community Dialogue and Mobilization for HIV Prevention

Spoken word, a form of performance poetry, is a promising approach to HIV/AIDS awareness and prevention, as it has the potential to encourage dialogue among and within communities and address concerns regarding the social stigma present in rural communities. The purpose of this study is to describe the development and implementation of the Spoken Word Project (SWP), an HIV/AIDS pilot intervention in rural North Carolina designed to improve HIV-related attitudes and self-efficacy and decrease stigma through the use of performance poetry. Spoken word is a collaborative effort between residents of two rural counties in North Carolina and Project GRACE (Growing, Reaching, Advocating for Change and Empowerment), a community-based participatory research collaboration aimed at reducing health disparities in African American communities. The project included 15 adult and youth participants. Results indicated that spoken word has the ability to build upon local resources, generate community reflection, and engage a broad spectrum of performers and audiences. Our findings also showed that the effect of stigma and limited community conversations about HIV in rural communities can be abated through the use of spoken word

Astro2020 APC White Paper. 2020 Vision: Towards a Sustainable OIR System

Open-access telescopes of all apertures are needed to operate a competitive and efficient national science program. While larger facilities contribute light-gathering power and angular resolution, smaller ones dominate for field of view, time-resolution, and especially, total available observing time, thereby enabling our entire, diversely-expert community. Smaller aperture telescopes therefore play a critical and indispensable role in advancing science. Thus, the divestment of NSF support for modest-aperture (1 – 4 m) public telescopes poses a serious threat to U.S. scientific leadership, which is compounded by the unknown consequences of the shift from observations driven by individual investigators to survey-driven science. Given the much higher cost efficiency and dramatic science returns for investments in modest aperture telescopes, it is hard to justify funding only the most expensive facilities. We therefore urge the Astro2020 panel to explicitly make the case for modest aperture facilities, and to recommend enhancing this funding stream to support and grow this critical component of the OIR System. Further study is urgently needed to prioritize the numerous exciting potential capabilities of smaller facilities,and to establish sustainable, long-term planning for the System

Empathy and emotion recognition in people with autism, first-degree relatives, and controls

Empathy is the lens through which we view others' emotion expressions, and respond to them. In this study, empathy and facial emotion recognition were investigated in adults with autism spectrum conditions (ASC; N=314), parents of a child with ASC (N=297) and IQ-matched controls (N=184). Participants completed a self-report measure of empathy (the Empathy Quotient [EQ]) and a modified version of the Karolinska Directed Emotional Faces Task (KDEF) using an online test interface. Results showed that mean scores on the EQ were significantly lower in fathers (p0.05) of children with ASC compared to controls, whilst both males and females with ASC obtained significantly lower EQ scores (p0.05). Finally, results indicated significant differences between males and females with ASC for emotion recognition performance (p0.05). These findings suggest that self-reported empathy deficits in fathers of autistic probands are part of the 'broader autism phenotype'. This study also reports new findings of sex differences amongst people with ASC in emotion recognition, as well as replicating previous work demonstrating empathy difficulties in adults with ASC. The use of empathy measures as quantitative endophenotypes for ASC is discussed

2020 Vision: Towards a Sustainable OIR System

Open-access telescopes of all apertures are needed to operate a competitive and efficient national science program. While larger facilities contribute light-gathering power and angular resolution, smaller ones dominate for field of view, time-resolution, and especially, total available observing time, thereby enabling our entire, diversely-expert community. Smaller aperture telescopes therefore play a critical and indispensable role in advancing science. Thus, the divestment of NSF support for modest-aperture (1 - 4 m) public telescopes poses a serious threat to U.S. scientific leadership, which is compounded by the unknown consequences of the shift from observations driven by individual investigators to survey-driven science. Given the much higher cost efficiency and dramatic science returns for investments in modest aperture telescopes, it is hard to justify funding only the most expensive facilities. We therefore urge the Astro2020 panel to explicitly make the case for modest aperture facilities, and to recommend enhancing this funding stream to support and grow this critical component of the OIR System. Further study is urgently needed to prioritize the numerous exciting potential capabilities of smaller facilities,and to establish sustainable, long-term planning for the System.Comment: Astro2020 APC White Pape

Incorporating Pharmacogenomics into Cancer Therapy

Heritable variations in genes associated with drug disposition and effects (i.e., drug metabolism, transport, and therapeutic target) contribute to individual heterogeneity in drug treatment response and tolerance. The terms pharmacogenetics or pharmacogenomics, which are often used interchangeably, refer to the study of how an individual’s genetic inheritance affects the body’s response to drugs and the use of this genetic information to predict the safety, toxicity, and/or efficacy of drugs in individual patients or groups of patients. In some cases, the term “pharmacogenetics” is used to refer to the study of differing phenotypes in association with a single gene or set of candidate genes and the term “pharmacogenomics” is used to refer to genome-wide approaches for identification or discovery of the genetic factors determining differing phenotypes. Throughout this chapter, the term “pharmacogenomics” will be used in reference to this scientific discipline. Pharmacogenomics, as it relates to cancer treatment, presents particular difficulties in comparison to other therapeutic areas, in that acquired somatic mutations in the tumors may also alter treatment outcomes and, that the narrow therapeutic window of chemotherapeutic agents makes titrations in drug dose to affect response or toxicity be a suboptimal approach. The application of pharmacogenomics into the treatment of cancer could have a considerable impact on optimizing cancer treatment for individual patients and groups of patients and also developing new chemotherapeutic agents